# OMONTYS
> **NDA202799** · New Drug Application · Sponsor: TAKEDA PHARMS USA · Approved 2012-03-27
## Drug
- **FDA Application Number:** NDA202799
- **Application type:** New Drug Application
- **Brand name:** OMONTYS
- **Generic name:** Peginesatide Acetate
- **Active ingredients:** PEGINESATIDE ACETATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS, SUBCUTANEOUS
- **Marketing status:** Discontinued
- **Sponsor:** TAKEDA PHARMS USA
- **First approval:** 2012-03-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202799)
---
*AI Analytics · CC0 1.0*